Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
7.47
+0.08 (1.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.51B in the quarter ending September 30, 2024, with 12.15% growth. This brings the company's revenue in the last twelve months to $9.47B, up 10.91% year-over-year. In the year 2023, Bausch Health Companies had annual revenue of $8.76B with 7.79% growth.
Revenue (ttm)
$9.47B
Revenue Growth
+10.91%
P/S Ratio
0.29
Revenue / Employee
$467,390
Employees
20,270
Market Cap
2.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Patterson Companies | 6.55B |
Amedisys | 2.32B |
LifeStance Health Group | 1.21B |
ACADIA Pharmaceuticals | 929.24M |
Neogen | 912.20M |
iRhythm Technologies | 560.03M |
Zai Lab | 355.75M |
Vericel | 226.84M |
BHC News
- 9 days ago - Contact lens maker Bausch + Lomb says it is exploring sale - Reuters
- 9 days ago - Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb - Accesswire
- 9 days ago - Bausch + Lomb Responds to Rumors of a Potential Sale - Business Wire
- 10 days ago - Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 10 days ago - Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities - Business Wire
- 15 days ago - Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News - Seeking Alpha
- 16 days ago - Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day - Accesswire
- 19 days ago - Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors - Seeking Alpha